OR

Browse By

Human Leukaemia Inhibitory Factor (hLIF): A Potential Anti-Atherosclerotic/Anti-Restenotic Agent (1998–2000)

Grant type:
NHMRC Project Grant
Researchers:

  • Associate Professor Barbara Rolfe

    Principal Research Fellow and GL
    Australian Institute for Bioengineering and Nanotechnology
    Principal Research Fellow and Group
    Australian Institute for Bioengineering and Nanotechnology
Funded by:
National Health and Medical Research Council